Ignite Creation Date:
2024-05-05 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 9:57 AM
Study NCT ID:
NCT00784147
Status:
COMPLETED
Last Update Posted:
2014-05-05
First Post:
2008-10-30
Brief Title:
Dose-Response Study of Ibalizumab Monoclonal Antibody Plus Optimized Background Regimen in Patients With HIV-1
Sponsor:
TaiMed Biologics Inc
Organization:
TaiMed Biologics Inc